A world-renowned
Harvard child psychiatrist whose work has helped fuel an explosion
in the use of powerful antipsychotic medicines in children earned at least $1.6
million in consulting fees from drug makers from 2000 to 2007 but for years did
not report much of this income to university officials, according to information
given Congressional investigators. …

John Burklow, a spokesman for the National Institutes of Health,
said: “If
there have been violations of N.I.H. policy – and if
research integrity has
been compromised – we will take all the
appropriate action within our power
to hold those responsible
accountable. This would be completely unacceptable
behavior, and
N.I.H. will not tolerate it.”
…